Replies to post #541 on Lipocine Inc (LPCN)

[grizzly2314]

I think it is very good news and also thinks it played a role in the LPCNs most recent CRL. Why would Clarus get its product approved while missing a few of the secondary endpoints and then petition the FDA not to approve any other oral T medications if they miss secondary endpoints? It makes no sense to me.